Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genomics In Cancer Care Market, by Application
1.4.2 North America Genomics In Cancer Care Market, by Product
1.4.3 North America Genomics In Cancer Care Market, by Technology
1.4.4 North America Genomics In Cancer Care Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Genomics In Cancer Care Market by Application
5.1 North America Diagnostics Market by Country
5.2 North America Personalized Medicine Market by Country
5.3 North America Drug Discovery & Development Market by Country
5.4 North America Research Market by Country
Chapter 6. North America Genomics In Cancer Care Market by Product
6.1 North America Instruments Market by Country
6.2 North America Consumables Market by Country
6.3 North America Services Market by Country
Chapter 7. North America Genomics In Cancer Care Market by Technology
7.1 North America PCR Market by Country
7.2 North America Genome Sequencing Market by Country
7.3 North America Microarrays Market by Country
7.4 North America Nuclei Acid Extraction & Purification Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Genomics In Cancer Care Market by Country
8.1 US Genomics In Cancer Care Market
8.1.1 US Genomics In Cancer Care Market by Application
8.1.2 US Genomics In Cancer Care Market by Product
8.1.3 US Genomics In Cancer Care Market by Technology
8.2 Canada Genomics In Cancer Care Market
8.2.1 Canada Genomics In Cancer Care Market by Application
8.2.2 Canada Genomics In Cancer Care Market by Product
8.2.3 Canada Genomics In Cancer Care Market by Technology
8.3 Mexico Genomics In Cancer Care Market
8.3.1 Mexico Genomics In Cancer Care Market by Application
8.3.2 Mexico Genomics In Cancer Care Market by Product
8.3.3 Mexico Genomics In Cancer Care Market by Technology
8.4 Rest of North America Genomics In Cancer Care Market
8.4.1 Rest of North America Genomics In Cancer Care Market by Application
8.4.2 Rest of North America Genomics In Cancer Care Market by Product
8.4.3 Rest of North America Genomics In Cancer Care Market by Technology
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 SWOT Analysis
9.8 Revvity, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
Unique Offerings 